ClinConnect ClinConnect Logo
Search / Trial NCT05466825

The Global Cardiovascular Risk Consortium

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Jul 18, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Cardiovascular Disease Cardiovascular Risk Factors Risk Factor Modification Global Lifetime Gain

ClinConnect Summary

The Global Cardiovascular Risk Consortium (GCVRC) is a large research study looking at how certain risk factors affect heart health and overall survival. The study collects and analyzes data from over 2.2 million people across many countries. Researchers are focusing on key factors like body weight, blood pressure, cholesterol levels, smoking habits, and diabetes to see how they relate to heart disease and the risk of dying from any cause.

To participate in this study, you need to be between the ages of 65 and up and have information available about the risk factors mentioned. Unfortunately, younger individuals, those with a history of heart disease, or those without complete health data are not eligible. If you join the study, you’ll help researchers understand how these risk factors impact health, which could lead to better prevention and treatment strategies for cardiovascular diseases in the future. Participation is ongoing, and your contribution could make a significant difference in heart health research worldwide.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Population-based individual-level data with available information on the classical cardiovascular risk factors including body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes, as well as the outcomes of interest.
  • Exclusion Criteria:
  • Participants with age below 18 years
  • No information on the outcome of interest
  • No information on the exposure of interest (CVD risk factors)
  • History of CVD at baseline

About Universitätsklinikum Hamburg Eppendorf

Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.

Locations

Hamburg, , Germany

Patients applied

0 patients applied

Trial Officials

Prof. Dr. med. Stefan Blankenberg

Study Chair

Universitätsklinikum Hamburg-Eppendorf

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials